Patents by Inventor Diane E. Griffin

Diane E. Griffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150224170
    Abstract: The invention provides methods of inhibiting alphavirus replication and treating alphavirus infection.
    Type: Application
    Filed: September 17, 2014
    Publication date: August 13, 2015
    Inventors: Diane E. Griffin, Michael Ayars
  • Publication number: 20130267460
    Abstract: The invention provides methods of inhibiting alphavirus replication and treating alphavirus infection.
    Type: Application
    Filed: September 16, 2011
    Publication date: October 10, 2013
    Applicant: The Johns Hopkins University
    Inventors: Diane E. Griffin, Michael Ayars
  • Publication number: 20120039935
    Abstract: The invention provides for a measles vaccine utilizing a human codon-optimized polynucleotide encoding a measles virus polypeptide, such as HA or F protein. Optionally, the vaccine is administered with an adjuvant and is especially useful for immunizing an infant mammal.
    Type: Application
    Filed: June 16, 2010
    Publication date: February 16, 2012
    Applicant: Vical Incorporated
    Inventors: Adrian Vilalta, Gretchen Jimenez, Diane E. Griffin
  • Publication number: 20090004203
    Abstract: The invention provides for a measles vaccine utilizing a human codon-optimized polynucleotide encoding a measles virus polypeptide, such as HA or F protein. Optionally, the vaccine is administered with an adjuvant and is especially useful for immunizing an infant mammal.
    Type: Application
    Filed: May 29, 2008
    Publication date: January 1, 2009
    Applicants: Vical Incorporated, JOHNS HOPKINS UNIVERSITY
    Inventors: Adrian Vilalta, Gretchen Jimenez, Diane E. Griffin
  • Patent number: 6086876
    Abstract: The invention includes compositions and methods for selective suppression of IL-12 production in a cell. Methods of treating a human having a disease associated with dysregulated IL-12 production are also provided.
    Type: Grant
    Filed: February 6, 1998
    Date of Patent: July 11, 2000
    Assignees: The Wistar Insitute, Johns Hopkins University
    Inventors: Christopher L. Karp, Giorgio Trinchieri, Maria Wysocka, Diane E. Griffin